Which response indicates a diagnosis of myasthenia gravis after Edrophonium administration?

Study for the Drugs for Neurological Disorders Test. Prepare with our comprehensive quizzes and flashcards. Each question includes detailed explanations to enhance your understanding. Get ready for success!

A diagnosis of myasthenia gravis can be indicated by an increase in muscle strength shortly after administration of Edrophonium, a short-acting acetylcholinesterase inhibitor. This drug temporarily enhances the availability of acetylcholine at the neuromuscular junction, which often leads to a rapid improvement in muscle strength for patients suffering from myasthenia gravis, where there is a blockade of acetylcholine receptors. The positive response typically occurs within 30 to 60 seconds after Edrophonium is administered, providing a clear diagnostic tool for this condition.

The other responses do not align with the expected outcomes for Edrophonium in patients with myasthenia gravis. A decrease in muscle strength, muscle spasms, or severe fatigue would not provide supportive evidence for a diagnosis of myasthenia gravis; rather, they indicate other issues or non-responsiveness to the treatment. The quick increase in muscle strength is a hallmark of the effectiveness of Edrophonium in diagnosing this neurological disorder.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy